VM
RGNX icon

VHCP Management’s Regenxbio RGNX Stock Holding History

VHCP Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,089
Closed -$337K – 23
2016
Q3 		$337K Sell
24,089
-28,411
-54% -$314K 0.33% 21
2016
Q2 		$420K Hold
52,500
– – 0.44% 21
2016
Q1 		$567K Hold
52,500
– – 0.49% 22
2015
Q4 		$872K Sell
52,500
-1,030,954
-95% -$20.5M 0.53% 20
2015
Q3 		$20.2M Buy
+1,083,454
New +$27.7M 5.17% 5

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VHCP Management's RGNX Position: Q4 2016 in Review

VHCP Management sold out of Regenxbio (RGNX) in Q4 2016, closing a stake of 24,089 shares — an estimated $337K sold.

VHCP Management first reported a position in RGNX in Q3 2015 and held it in 5 quarters. The position peaked at $20.2M in Q3 2015. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

  • VHCP Management reported no remaining Regenxbio position as of Q4 2016 after selling out during the quarter.
  • VHCP Management sold 24,089 Regenxbio shares in Q4 2016, an estimated $337K.
  • VHCP Management first reported a position in Regenxbio in Q3 2015 and held it in 5 quarters.
  • VHCP Management's Regenxbio position peaked at $20.2M in Q3 2015.
  • 78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.